Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

A rare FAA nationwide ground stop tied to an air-traffic-control communications failure is driving attention to Delta and other airlines, with traders weighing potential disruption against the sectors modest share-price reaction. Some speculate about a cyberattack or other cause, but the cause has not been confirmed.

The FAAs nationwide ground stop, prompted by an air-traffic-control communications failure, is driving attention to American and other airline stocks. Traders expect a temporary disruption, while some speculate about a cyberattack or other cause; those explanations remain unconfirmed.

Starship Flight 15 is driving attention: the launch and satellite deployment succeeded, but a safety check aborted the Super Heavy boosters tower catch, leading to a controlled splashdown in the Gulf. Traders are divided over whether the abort shows prudent safety procedures or a setback for rocket reusability, while the planned Starship upper-stage catch remains a separate milestone.

CEO Paul Gus reported purchase of 50,000 shares is drawing attention, with some traders viewing it as a confidence signal and linking it to speculation about a bank charter. Others remain bearish, citing past insider buys that preceded declines, heavy put options activity, and unverified bankruptcy concerns amid the stocks prolonged slide.

Traders are speculating that the FAAs nationwide flight ground stop could have a cyber angle, drawing attention to CrowdStrike and other cybersecurity stocks; the FAA has not attributed the disruption to a cyberattack. Some see the incident as a potential boost to security demand, while others question whether cybersecurity shares should benefit before the cause is known.

A nationwide FAA ground stop tied to an air-traffic communications failure is driving attention, with traders weighing potential disruption to airline operations. Speculation about a cyberattack or AI-related cause is circulating, but the cause remains unconfirmed.

Summit is drawing attention ahead of the FDAs decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer. Traders are split between approval hopes, citing strong progression-free-survival results and AstraZenecas investment, and CRL concerns because the trial missed statistical significance on overall survival; some interpret the share-price weakness as a possible signal, though that remains speculation.

Traders are focused on Trulieves reported Russell index inclusion, anticipating purchases by index-tracking funds and trading around the reconstitution. Some see it as a near-term tailwind, while others argue inclusion may have limited impact amid cannabis-sector weakness and uncertainty over broader Schedule III rescheduling.

Intellias long-term lonvo-z data for hereditary angioedema, showing a sustained reduction in attacks and limited need for ongoing prevention, is drawing attention alongside the unchanged March 2027 FDA decision date. Traders are debating why shares fell despite the positive update, citing broad pressure on speculative biotech and suspected short-selling, while skeptics point to commercial execution and the long wait for approval.

The FAAs nationwide flight ground stop has traders speculating that a cyber incident may be involved, though the stated cause is a communications issue and no cyberattack has been confirmed. Some see the disruption as a potential boost to cybersecurity spending, while others are frustrated that PANW and its peers have not reacted more strongly.